Management

Avishay Bransky, Ph.D.

CEO, Co-founder

Avishay Bransky, Ph.D., CEO and co-founder of PixCell, is an expert in microfluidics, with extensive industrial experience in applied physics, software and systems engineering.

Avishay Bransky, Ph.D.

CEO, Co-founder

Avishay Bransky, Ph.D., CEO and co-founder of PixCell, is an expert in microfluidics, with extensive industrial experience in applied physics, software and systems engineering.

He is one of the inventors of the Viscoelastic Focusing technique, cell analysis methods and the microfluidic based cartridge.

Prior to his position at PixCell, Dr. Bransky served as the CEO of HemoScreen, a subsidiary of PixCell, and led R&D projects at leading Israeli high tech companies: Elscint, Qualcomm and Trellis Photonics.

Dr. Bransky holds a B.A. in Physics, B.Sc. in Materials Engineering and a Ph.D. in Biomedical Engineering, all from the Technion Israel Institute of Technology.

Prof. Max Herzberg

Co-founder

Prof. Max Herzberg, Co-Founder of PixCell, is a well-known scientist and entrepreneur and one of the founding fathers of the Israel life sciences industry.

Prof. Max Herzberg

Co-founder

Prof. Max Herzberg, Co-Founder of PixCell, is a well-known scientist and entrepreneur and one of the founding fathers of the Israel life sciences industry.

He founded Orgenics and the EagerBio Group, served as chairman of several biotechnology companies in Israel and as chairman of the European Molecular Biology Laboratory Enterprise Management (Heidelberg, Germany). He is currently the active chairman of Vidac Pharma.

Prof. Herzberg holds a Ph.D. in Molecular Biology from the Weizmann Institute of Science.

Hanan Ben-Asher

COO and BD Manager

Hanan Ben-Asher is an experienced business executive with expertise in multidisciplinary research and development and a strong background in medical device development.

Hanan Ben-Asher

COO and BD Manager

Hanan Ben-Asher is an experienced business executive with expertise in multidisciplinary research and development and a strong background in medical device development.

Prior to his position at PixCell Hanan served as R&D manager at Medoc Advanced Medical Systems.

He holds a B.Sc. (cum laude) in Biomedical Engineering and an MBA, both from the Technion Israel Institute of Technology.

Yaara Ben-Yosef, Ph.D

Director of RA and Clinical Affairs

Yaara Ben-Yosef is a Regulatory and Clinical Affairs expert with track
record success in R&D of complex biological processes for healthcare
industry. Experienced with clinical trials design and monitoring.

Yaara Ben-Yosef, Ph.D

Director of RA and Clinical Affairs

Yaara Ben-Yosef is a Regulatory and Clinical Affairs expert with track
record success in R&D of complex biological processes for healthcare
industry. Experienced with clinical trials design and monitoring.

Board of Directors

David Stein, Ph.D.

Chairman of the Board

Dr. David Stein is the Board Chairman of PixCell Medical. David is currently focused on advising and investing in Start-up and growth companies as a founder, advisor, and Board Member. David is also c...

David Stein, Ph.D.

Chairman of the Board

Dr. David Stein is the Board Chairman of PixCell Medical. David is currently focused on advising and investing in Start-up and growth companies as a founder, advisor, and Board Member. David is also currently the CEO at Babson Diagnostics in Austin Texas.

Armin Schon, Ph.D.

Director

Armin Schon, Ph.D. is an experienced director with broad multidisciplinary experience in medical and analytical devices. He is an expert in strategy and business development....

Armin Schon, Ph.D.

Director

Armin Schon, Ph.D. is an experienced director with broad multidisciplinary experience in medical and analytical devices. He is an expert in strategy and business development.

Abraham Gross, Ph.D.

Director

Abraham Gross, Ph.D. serves as Chief Technology Officer and Executive Vice President of Orbotech Ltd since May 2006 and its Head of Innovation since October 2016. Dr. Gross served as a Technical Advis...

Abraham Gross, Ph.D.

Director

Abraham Gross, Ph.D. serves as Chief Technology Officer and Executive Vice President of Orbotech Ltd since May 2006 and its Head of Innovation since October 2016. Dr. Gross served as a Technical Advisor and Chief Scientist of Orbotech Ltd. until 2006 and its Corporate Executive Vice President for Technology and Innovation from October 2014 to October 2016. Dr. Gross leads Orbotech’s advanced research in optical techniques for testing and inspection, as well as the development of new technologies for laser application in the electronics industry.

He is the author of numerous patents and published scientific works.

Dr. Gross holds a Ph.D. in Physics and Atmospheric Science from Drexel University, Philadelphia.

Lior Maayan

Director

Lior Maayan serves as Corp. VP Strategy, Business Development & Chief Marketing Officer at Orbotech. Prior to his position at Orbotech he served as CEO of OrSense and COO at Compugen. While at Compuge...

Lior Maayan

Director

Lior Maayan serves as Corp. VP Strategy, Business Development & Chief Marketing Officer at Orbotech. Prior to his position at Orbotech he served as CEO of OrSense and COO at Compugen. While at Compugen he served as member of the first Israeli National Biotechnology Committee.

Lior Maayan holds a B.Sc. in Physics and Mathematics from the Hebrew University in Jerusalem, a Masters degree in Behavioral Sciences from the Technion, the Technology Institute of Israel in Haifa and an MBA from INSEAD.

Shmuel Cabilly, Ph.D.

Director

Shmuel Cabilly, Ph.D., is a leading scientist and inventor in the field of immunology. His patented inventions related to recombinant antibody production have led to the development of widely used dru...

Shmuel Cabilly, Ph.D.

Director

Shmuel Cabilly, Ph.D., is a leading scientist and inventor in the field of immunology. His patented inventions related to recombinant antibody production have led to the development of widely used drugs, such as Herceptin, Rituxan, Avestin and others.

Dr. Cabilly was the co-founder and chief scientist of Ethrog Biotechnology, where he invented dry buffer technologies that enable the production of a disposable apparatus for gel electrophoresis containing no liquid and a technology that enables the condensation of molecule separation zones to a small gel area.

Dr. Cabilly holds a Ph.D in Immunology from the Hebrew University in Jerusalem.

Scientific Advisory Board

Prof. Robert H. Christenson

Dr. Christenson is Professor of Pathology and Professor of Medical and Research Technology at the University of Maryland School of Medicine in Baltimore, Maryland. Clinically, Dr. Christenson is Medic...

Prof. Robert H. Christenson

Dr. Christenson is Professor of Pathology and Professor of Medical and Research Technology at the University of Maryland School of Medicine in Baltimore, Maryland. Clinically, Dr. Christenson is Medical Director of the Core Laboratories and Point of Care Testing at the University of Maryland Medical Center. Academically, Dr. Christenson has published over 310 peer-reviewed papers, 6 books, 32 textbook chapters and holds four patents. He has an active research program in the area of biomarkers with focused interests of heart disease, renal disease, oncology and stroke. His Clinical Core Research Laboratory (CCRL) has been involved in many studies aimed at achieving FDA clearance of in vitro diagnostics. He also has a long standing interest in Evidence-Based Laboratory Medicine and has chaired both AACC and IFCC committees on this topic.

Prof. Sharon Geaghan

Dr. Geaghan is Emeritus Chief, Pathology and Director of Clinical Laboratories at the Lucile Salter Packard Children's Hospital at Stanford, a position she held for 21 years. After residency and fello...

Prof. Sharon Geaghan

Dr. Geaghan is Emeritus Chief, Pathology and Director of Clinical Laboratories at the Lucile Salter Packard Children's Hospital at Stanford, a position she held for 21 years. After residency and fellowship training at the University of California San Francisco, where she served as Chief Resident, she immediately assumed this leadership position. She holds five board certifications in Anatomic and Clinical Pathology, Hematology, Pediatric Pathology and Clinical Informatics.

Dr. Geaghan developed the dedicated pediatric clinical diagnostic service at Stanford for the first decade of her career, and then served as one of four Medical Directors overseeing the merged four-hospital University of California San Francisco-Stanford Clinical Laboratories (1997-1999). In 2001, she became Co-Medical Director for Pediatrics of the Stanford Hospital and Clinics Clinical Laboratories, which included the merged adult and pediatric services, a position she held simultaneously with the Chief, Pathology at the Children’s hospital.

Prof. Anders Larsson

Anders Larsson is Professor of laboratory science with emphasis on health economics at the Department of Medical Sciences. He heads a research group focusing on assay development and the use of avian ...

Prof. Anders Larsson

Anders Larsson is Professor of laboratory science with emphasis on health economics at the Department of Medical Sciences. He heads a research group focusing on assay development and the use of avian antibodies.

Peter Hansen, Ph.D., AIMBE Fellow

Peter Hansen received his degrees from Harvard College and Northeastern University and holds a PhD in the fields of Biophysics and Biomedical Engineering. In 2010, he was chosen to be a Fellow of the ...

Peter Hansen, Ph.D., AIMBE Fellow

Peter Hansen received his degrees from Harvard College and Northeastern University and holds a PhD in the fields of Biophysics and Biomedical Engineering. In 2010, he was chosen to be a Fellow of the American Institute for Medical and Biological Engineers for three decades of inventions in flow cytometry. He has served on the engineering staff of Northeastern University in Boston, Massachusetts and Massachusetts Institute of Technology in Cambridge, Massachusetts before entering a career in commercial science. While at Northeastern he discovered second harmonic generation in biological tissues and established a nonlinear optics technique for quantifying molecular order in connective tissue. This was the first of the now many applications of nonlinear optics (harmonic generation and multi-photon optics) in biology and medicine.

Dev by RNCode | Design by Adi